Background: Experimental models with reversible biliary occlusion resulted in a high mortality of the animals, up to 20-60% according to the literature. Our aim was to assess a safe and valid technique for reversible biliary occlusion with a low mortality. Methods: We randomized 30 rats into two groups: with bile duct occlusion (BDO, n = 18) and with sham mani pulation of the extrahepatic bile duct (control, n = 12). We used a removable vascular clip for temporary occlusion of the extrahepatic bile duct. The clip was removed on post operative day (POD) 2. On POD 2, 3, and 5, we measured the hepatocellular injury and metabolic function markers in serum. Activation of mononuclear cells (HIS36) and expression of regeneration markers [cytokeratin 19, hepatic growth factor (HGF)α, and HGFβ] were deter mined by immunohistochemistry. Results: The survival rate was 96.67% (1/30); one animal died. The mortality in the BDO group was 6% (1/18) and that in the control group was 0% (0/12). BDO resulted in a sharp increase of hepatocellular injury and choles tatic parameters on POD 2 with a rapid decline till POD 3. Significantly strongest activation of Kupffer cells and expression of proliferation markers were found until POD 5 after BDO.
Introduction
To study the mammalian pathophysiology of obstructive cholestasis, the most favorite model is bile duct ligation (BDL) mimicking a biliary obstruction of varying extent [1] [2] [3] [4] [5] [6] [7] [8] . The liver parenchyma develops a histological con version into a fibrotic or a cirrhotic pattern depending on the duration of biliary obstruction.
Primarily, the focus has been paid to histological alterations like the increase in relative size of the biliary compartment including proliferation of biliary epithe lial cells (using CK19) and of interportal fibrous tissue [6, 7] . In these studies, BDL lasted up to 4 weeks [1] [2] [3] [4] [5] [6] 8] . Later on, metabolic parameters such as gluconeo genesis, glycogen content, and lipid oxidation were also investigated [1] [2] [3] [4] [5] [6] [7] 9] . Several studies have shown that some of these structural and metabolic changes were reversible after relief of biliary obstruction [1] [2] [3] [4] [5] [6] . BDL was performed by ligating the common bile duct with several sutures. The relief of the biliary occlusion was facilitated by RouxenY choledochojejunostomy, as it is known as a standard procedure for a biliodigestive anas tomosis in humans. Because of the impact of the second operation on the reduced hepatocellular regenerative capacity due to cholestasis, the mortality of the animals was mostly as high as 17-40% [2] [3] [4] 10] . To avoid mor tality, we assessed a new technique for temporary bile duct occlusion (BDO) with inherently less morbidity and mortality.
Materials and methods

Animals
All surgical procedures were performed in inbred male Sprague Dawley rats (Charles River, Germany) aged 9-10 weeks [body weight (BW) 250-280 g].
Institutional animal care and use committee statement: Rats were fed a standard laboratory diet with water and rat chow ad libitum until harvest. All animals were kept under constant environmen tal conditions with a 12h lightdark cycle in a conventional animal facility using environmentally enriched type IV cages in groups of two to three rats. All procedures and housing of the animals were carried out according to the German Animal Welfare Legislation and approved by the local authorities (Hessisches Landesamt für Verbraucherschutz, reg.nr. 02025/08). Analgesic treatment was started immediately after wound closure in all animals. Buprenor phine (0.05 mg/kg BW; Temgesic ® ) was subcutaneously injected; the analgesic therapy was given twice a day during the first 3 days postoperatively. For postoperative monitoring, the rats were weighed daily.
Study design
The 30 animals were randomized into two groups: laparotomy with BDO (n = 18) and sham manipulation of the extrahepatic bile duct without occlusion (control, n = 12). On postoperative day (POD) 2, the clip was removed in all BDO rats. At three different time points (POD 2, 3, and 5), the animals (BDO with n = 6 per time point, control with n = 4 per time point) were sacrificed and samples (serum, liver tissue) were collected.
Surgical procedures
All groups were anaesthetized with an intramuscular injection of ket amine (10 mg/100 g BW) and xylazine (1 mg/100 g BW). The animals were shaved and placed on a small animal operating table. As the operation time for placing and removing the clip was always approxi mately 10 min, we avoided using a warming plate.
BDO group -laparotomy with BDO: After midline laparotomy, the common bile duct was exposed and occluded 0.5-1 cm above the pancreas using a removable vascular clip. The wounds were closed by running sutures. After 2 days (POD 2), a relaparotomy was per formed and the clip was removed. The wounds were closed.
The vascular titan clip was placed and removed using a special clipforceps (Aesculap AG, Germany; vascular bulldog clip straight 25 mm). The used forceps ensured correct placing of the clip and simultaneously avoided overtension of the gentle clip and damage of the common bile duct or the surrounding organs. We selected a vascular clip with a low but sufficient closing force of 2.4 N with atraumatic toothing "DeBakey," as a higher closing force could lead to residual obstruction resulting in remaining dilatation of the extra hepatic bile duct.
Control group -laparotomy with sham manipulation of the bile duct: These animals underwent anesthesia and laparotomy, as described, and exposure of the common bile duct without occlusion ("sham procedure"). The control animals received a second laparot omy at the time point of sacrifice.
Characterization of the animals
Food intake and BW gain were measured daily. No pairfeeding was performed. At the indicated time points of death, liver and spleen weight were measured.
Tissue preparation
At the dedicated time points and under anesthesia, a laparotomy was performed and a blood sample was collected into sterile tubes. The blood was allowed to clot. During all procedures, the sam ples were kept at 4 °C. Immediately after sacrifice of the animals, liver samples were placed in Shandon™ Cryomatrix™ embedding medium (Thermo Fisher Scientific, UK) and quickly cooled in liq uid nitrogen for subsequent cryosectioning for immunohistochem istry. For detection of the systemic parameters, blood samples were taken from the retrobulbar venous plexus preoperatively and at days 2, 3, 4, and 5. The blood was allowed to clot. During all procedures, the samples were kept at 4 °C. All specimens were kept at −80 °C until subsequent analyses were performed. Rats do not have a gallbladder.
Laboratory measurements
Measurements in serum: The activities of alkaline phosphatase (U/L), aspartate aminotransferase (U/L), alanine aminotransferase (U/L), γglutamyltransferase (U/L), and the contents of albumin (g/dL), bilirubin (mg/dL), glucose (mmol/L), cholesterol (mg/dL), triglycerides (mg/dL), and whole protein (g/dL) were measured in serum using an automated chemical analyzer (Bayer Advia 1650, Germany).
Staining and immunohistochemistry
For histological evaluation, we used a standardized sampling of three pieces of every liver. Acetonefixed, 5μm frozen liver sections were stained with hematoxylin and eosin in order to evaluate altera tions of the liver parenchyma and bile duct hyperplasia.
Immunohistological detection of activated Kupffer cells was done by using monoclonal antiratmacrophage antibody [HIS36 mouse antirat (22231D); Pharmingen Biotechnology, Germany] diluted 1:700 in phosphatebuffered saline (PBS; pH 7.4-7.5, without Ca 2+ and Mg 2+ ), applied to the frozen liver sections and incubated at 37 °C for 60 min. Staining procedures were performed as already published by our group [11] .
Immunohistological detection of biliary neoangiogenesis [cytokeratin 19 (CK19)] was performed by using monoclonal mouseantirat readytouse antibody [CK19, mouse antirat (22231D); Pharmingen Biotechnology, Germany] with PBS (pH 7.4-7.5, without Ca 2+ and Mg
2+
) applied to the frozen liver sections and incubated at 37 °C for 60 min. The staining procedure was performed with a com mercial set provided by Progen Biotechnik GmbH [mouse IgG2b, monoclonal antibody CK19 (Ks 19.2)]. Incubation times were set and washing procedures were performed as described in the manufac turer's manual.
The immunohistological detection of hepatic growth factors (HGFα and β) followed the abovedescribed procedure with dilution of the primary antibodies at 1:50 in PBS [antiHGFα and antiHGFβ (N19) sc1356], application to the frozen liver sections, and incubation at 37 °C for 60 min. The next steps were performed with a commer cial set of secondary and tertiary antibodies provided by Santa Cruz Pharmaceuticals (Goat ABC Staining System Kit; Santa Cruz Biotech nology, sc2023). Incubation times were set and washing procedures were performed as described in the manufacturer's manual.
Negative and positive controls were made using five slides for each staining (primary antibodies) and with additional control slides from random organs.
Quantification of immunohistochemistry
Liver cryostat sections were analyzed microscopically using a mor phometric analysis system (CBA 8000Manager; Leica, Germany). We manually counted CK19positive cells in 10 highpower fields (HPFs, 20× magnification) and calculated the ratio of CK19positive cells per total cholangiocytes. The expression was graduated into four grades (Table 1) . Kupffer cells, CK19, and HGFα+β were evaluated according to this standardized protocol [11] .
Statistics
Data are presented as mean ± standard deviation (SD). We used the parametric descriptors due to the type of data distribution and per formed statistical tests in coordination with a statistician.
The data were analyzed for the type of distribution by using the onesample KolmogorovSmirnov test (OSKST). Normal distribution was accepted if p > 0.05 (twotailed significance, corrected for ties). For all parameters, the OSKST showed no normal distribution. There fore, statistical evaluation for significance was performed using the KruskalWallis test. Significance was accepted in all cases at p < 0.05 (twotailed significance, corrected for ties). All statistical proce dures were performed using SPSS ® 22.0 for Windows (SPSS Science
International, Chicago, IL, USA). All statistical analyses were con ducted in coordination with a statistician.
Results
Safe and easy administration of the vascular clip for temporary biliary occlusion
In all BDO animals, the clip was easy and safe to place at the extrahepatic bile duct above the pancreas. As we placed the clip under the control of a microscope and by using the clipforceps, we avoided any impairment of the branches of the hepatic artery, portal vein, and pan creas. Furthermore, the microscope and forceps assured the placement of the clip below the bile duct branches of the lower liver lobes (right lobes and caudate lobes), pre venting a nonintended incomplete BDO ( Figure 1A-D) .
In all BDO animals, we found a macroscopically visible dilatation of the extrahepatic bile duct above the clip ( Figure 1A -D) until POD 2. We have not seen any dis location of the clip or damage of the neighboring liver lobes. On POD 2, the clip was easy to remove using the clipforceps without any additional surgical manipula tion (e.g. adhesiolysis, thermic or mechanic coagulation) besides the relaparotomy. Interestingly, shortly after (≤5 min) the retrieval of the clip, the massive dilatation of the main bile duct was reduced to a slightly dilated common bile duct. No persistent dilatation of extrahepatic bile duct has been noted on POD 3 and POD 5, respectively. In all BDO animals, we found a slightly green staining of the liver indicating intrahepatic cholestasis after 48 h of BDO (POD 2). Until 72 h (POD 5) after the removal of the clip, the tissue staining disappeared in all BDO animals. Few drops of clear ascites were found only in two BDO animals (2/18): in n = 1 on POD 3 and n = 1 on POD 5. The control animals showed neither ascites nor a modified coloring of the liver.
Situs pictures Survival and recovery of the animals
The survival rate of all animals was 96.67%; only one animal (1/30, 3.33%) died. Death occurred in a BDO animal on POD 3 (24 h after clip removal). The mortality rate in the BDO group was 6% (1/18) and that in the control group was 0% (0/12). Autopsy could exclude surgical complications like bleeding, ischemia, organ damages, or peritonitis. Therefore, it seems that an anesthesiarelated problem led to the death of the animal. All surviving animals showed an uncomplicated recovery during the observation period. No significant differences between the groups were found regarding BW, food intake, and liver and spleen weights (data not shown).
Serum parameters
BDO resulted in a significantly strong increase in all sys temic parameters compared to control on POD 2 ( Table 2) . With restored bile flow, nearly all parameters declined to normal values on POD 3 (Table 3 ). Only the activities of aspartate aminotransferase and alkaline phosphatase remained significantly elevated until POD 5 ( Table 2) . Glucose was significantly depressed after BDO until POD 3 and returned to normal levels until POD 5 (Table 3) . Cho lesterol was increased on POD 2 after BDO, followed by a rapid decline to normal values (Table 3) . Whole protein content and triglycerides were not significantly altered after BDO or in control.
Immunohistochemistry
We found a threefold increase of the expression of HGFα and HGFβ after BDO till POD 5 in comparison to control (Table 4) . HGFα was predominantly expressed in the area between the central veins and the portal fields, whereas HGFβ was expressed in the periportal areas and near the central veins (Figures 2A-D and 3A-D) . Following BDO, CK19 showed a constant and nearly twofold increase till POD 5 (Table 4) . A strong expres sion was localized around the portal fields and a weaker expression toward the central veins ( Figure 4A-D) .
Activation of Kupffer cells (HIS36) showed a signifi cant increase on POD 3 after BDO, followed by a stepwise decrease till POD 5 in comparison to control. The strong est increase in the numbers of resident macrophages was found at the portal fields, whereas a weaker activation was found toward the central veins ( Figure 5A-D) .
Discussion
Within the last decades, numerous studies explored the impact of temporary biliary occlusion on liver function and liver histology [1-3, 5, 6] . Only few authors reported about their survival data; the mortality of the animals was mostly as high as 17-40% [2-4, 10]. Most of them described the highest mortality within 1-5 days after the biliary drainage operation [3, 5] . The authors identified the combination of additional surgical trauma, the pro inflammatory response, and the increased hepatocellular metabolic and proliferative demand due to the second operation with a reduced hepatic regenerative capacity due to the biliary occlusion to be the critical factors for the high mortality in this experimental setting [2] [3] [4] [5] .
To avoid these unfavorable results, we searched for an alternative technique for temporary BDO with inherently less morbidity and mortality. We used a titan vascular clip to occlude the common bile duct (Figure 1A-D) . The clip was easy to place and to remove without any additional surgical trauma within the second operation. In our study, only 1 of the 30 animals died (survival: 96.67% with 29/30; mortality: BDO 6% with 1/18 vs. control 0% with 0/12). Autopsy could exclude surgical complications. The appli cation of the clip devise was always done under direct control of a microscope, assuring the ascertained arterial and portalvenous blood supply. Therefore, the new tech nique for temporary BDO using a vascular clip is a safe, fast, and inexpensive method without significant mortal ity. Similar observations concerning safety and usage of a The rats studied had either BDO for 2 days or sham laparotomy (control). On POD 2, the bile flow was restored by removal of the clip devise. Data are given as mean ± SD.
vascular clip device were published by Jorge with experi mental intermittent hepatic pedicle clamping and tempo rary choledochal clamping (~10 min) in rats [7, 12, 13] .
The second endpoint in our study was the suitability of the clip to induce comparable systemic and histologi cal alterations, as already described with the "ligation technique of BDL" [7, 8, [12] [13] [14] [15] . BDO led to a strong increase in systemic cholestatic parameters, while after removal of the clip we determined a rapid decline of these parameters [7, 8, [12] [13] [14] [15] . Interestingly, in our setting, the common bile duct showed no remaining dilatation after the removal of the vascular clip. In contrast, Jorge described in his setting (his clip was removed after 10 min) a residual dilatation of the main bile duct for up to 28 days [12, 13] . As Jorge described no further details of the used vascular clip, it led to the suspicion that the closing force is a crucial factor for visible and remaining dilatation of the main bile duct. Therefore, we selected a vascular clip with a low but sufficient closing force of 2.4 N with atraumatic toothing "DeBakey." A higher closing force could lead to residual obstruction resulting in remaining dilatation of the extra hepatic bile duct. We found no dislocation of the vascu lar clip or signs of mechanical damage of the neighboring organs (e.g. liver lobes, pancreas, branches of hepatic artery, and portal vein) by the clip.
The impressive and fast expression of proliferation markers underlines the fast response and the high activity level of the biliary epithelial cells even in our short obser vation time. However, our data are in line with former publications of shortterm cholestasis using the "ligation technique" [6, 7, 16, 17] . Therefore, BDO using the clip induced a comparable regenerative response of the liver parenchyma, as described with the "ligation technique." Furthermore, the fast and notable activation of Kupffer cells correspond to the results of Gregory and Tracy using the "ligation technique" [16] [17] [18] .
Hence, our "clip technique" led to comparable results like the "ligation technique" and resulted in a signifi cantly lower mortality of the animals. Therefore, our clip technique was a safe and valid method for induction of reversible occlusive cholestasis in small animals.
Conclusion
In summary, the vascular clip is a safe, minimally inva sive, inexpensive, and valid technique for the induction of obstructive cholestasis without the risk of a high mortality of the animals as described with the "ligation technique."
Further investigations regarding the appropriateness of the clip device for longterm obstructive cholestasis (≥2 weeks) and comparable restoration of the bile flow are needed and currently under way. 
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